184 related articles for article (PubMed ID: 25187119)
21. Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg.
Wark JD; Bensen W; Recknor C; Ryabitseva O; Chiodo J; Mesenbrink P; de Villiers TJ
Osteoporos Int; 2012 Feb; 23(2):503-12. PubMed ID: 21331467
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older.
Boonen S; Black DM; Colón-Emeric CS; Eastell R; Magaziner JS; Eriksen EF; Mesenbrink P; Haentjens P; Lyles KW
J Am Geriatr Soc; 2010 Feb; 58(2):292-9. PubMed ID: 20070415
[TBL] [Abstract][Full Text] [Related]
23. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
Reid DM; Devogelaer JP; Saag K; Roux C; Lau CS; Reginster JY; Papanastasiou P; Ferreira A; Hartl F; Fashola T; Mesenbrink P; Sambrook PN;
Lancet; 2009 Apr; 373(9671):1253-63. PubMed ID: 19362675
[TBL] [Abstract][Full Text] [Related]
24. Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial.
Billington EO; Horne A; Gamble GD; Maslowski K; House M; Reid IR
Osteoporos Int; 2017 Jun; 28(6):1867-1874. PubMed ID: 28233020
[TBL] [Abstract][Full Text] [Related]
25. Duration of antiresorptive activity of zoledronate in postmenopausal women with osteopenia: a randomized, controlled multidose trial.
Grey A; Bolland MJ; Horne A; Mihov B; Gamble G; Reid IR
CMAJ; 2017 Sep; 189(36):E1130-E1136. PubMed ID: 28893875
[TBL] [Abstract][Full Text] [Related]
26. A case report: zoledronic acid-induced anterior uveitis.
Kilickap S; Ozdamar Y; Altundag MK; Dizdar O
Med Oncol; 2008; 25(2):238-40. PubMed ID: 18488162
[TBL] [Abstract][Full Text] [Related]
27. Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid.
Silverman SL; Kriegman A; Goncalves J; Kianifard F; Carlson T; Leary E
Osteoporos Int; 2011 Aug; 22(8):2337-45. PubMed ID: 21116816
[TBL] [Abstract][Full Text] [Related]
28. Zoledronate Increases Bone Mineral Density in Nonambulant Children With Cerebral Palsy: A Randomized Controlled Trial.
Granild-Jensen JB; Møller-Madsen B; Rackauskaite G; Farholt S; Søndergaard C; Sørensen TH; Vestergaard ET; Langdahl BL
J Clin Endocrinol Metab; 2023 Oct; 108(11):2840-2851. PubMed ID: 37235798
[TBL] [Abstract][Full Text] [Related]
29. Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.
Shane E; Cohen A; Stein EM; McMahon DJ; Zhang C; Young P; Pandit K; Staron RB; Verna EC; Brown R; Restaino S; Mancini D
J Clin Endocrinol Metab; 2012 Dec; 97(12):4481-90. PubMed ID: 23024190
[TBL] [Abstract][Full Text] [Related]
30. Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer.
El Saghir NS; Otrock ZK; Bleik JH
BMC Cancer; 2005 Dec; 5():156. PubMed ID: 16332258
[TBL] [Abstract][Full Text] [Related]
31. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
Black DM; Delmas PD; Eastell R; Reid IR; Boonen S; Cauley JA; Cosman F; Lakatos P; Leung PC; Man Z; Mautalen C; Mesenbrink P; Hu H; Caminis J; Tong K; Rosario-Jansen T; Krasnow J; Hue TF; Sellmeyer D; Eriksen EF; Cummings SR;
N Engl J Med; 2007 May; 356(18):1809-22. PubMed ID: 17476007
[TBL] [Abstract][Full Text] [Related]
32. Drug-induced ocular inflammation.
Samalia P; Sims J; Niederer R
N Z Med J; 2020 Dec; 133(1527):83-94. PubMed ID: 33332330
[TBL] [Abstract][Full Text] [Related]
33. Duration of antiresorptive effects of low-dose zoledronate in osteopenic postmenopausal women: a randomized, placebo-controlled trial.
Grey A; Bolland M; Mihov B; Wong S; Horne A; Gamble G; Reid IR
J Bone Miner Res; 2014 Jan; 29(1):166-72. PubMed ID: 23761303
[TBL] [Abstract][Full Text] [Related]
34. Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report.
Tian Y; Wang R; Liu L; Ma C; Lu Q; Yin F
BMC Musculoskelet Disord; 2016 Feb; 17():72. PubMed ID: 26867651
[TBL] [Abstract][Full Text] [Related]
35. Effect of a Three-Day Course of Dexamethasone on Acute Phase Response Following Treatment With Zoledronate: A Randomized Controlled Trial.
Murdoch R; Mellar A; Horne AM; Billington E; Chan PL; Gamble GD; Reid IR
J Bone Miner Res; 2023 May; 38(5):631-638. PubMed ID: 36970850
[TBL] [Abstract][Full Text] [Related]
36. Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.
Crawford BA; Kam C; Pavlovic J; Byth K; Handelsman DJ; Angus PW; McCaughan GW
Ann Intern Med; 2006 Feb; 144(4):239-48. PubMed ID: 16490909
[TBL] [Abstract][Full Text] [Related]
37. Bilateral Ocular Pain and Hyperemia in a Patient With Paget Disease of the Bone.
Haider AS; Burbidge AM; Dunlop A
JAMA Ophthalmol; 2017 Jun; 135(6):665-666. PubMed ID: 28358955
[No Abstract] [Full Text] [Related]
38. A single dose of intravenous zoledronate prevents glucocorticoid therapy-associated bone loss in acute flare of Crohn's disease, a randomized controlled trial.
Klaus J; Haenle MM; Schröter C; Adler G; von Boyen G; Reinshagen M; von Tirpitz C
Am J Gastroenterol; 2011 Apr; 106(4):786-93. PubMed ID: 21386830
[TBL] [Abstract][Full Text] [Related]
39. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
[TBL] [Abstract][Full Text] [Related]
40. The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women.
Grey A; Bolland MJ; Wattie D; Horne A; Gamble G; Reid IR
J Clin Endocrinol Metab; 2009 Feb; 94(2):538-44. PubMed ID: 19050050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
